Inactive Instrument
Protide Pharmaceuticals, Inc. Stock
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +83.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 18/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +83.33% | +46.67% | - | - | 886K | ||
| -1.34% | -3.09% | +56.10% | +68.83% | 65.45B | ||
| -0.07% | -3.14% | +7.70% | +90.55% | 58.93B | ||
| +0.72% | +0.78% | +26.74% | +87.91% | 55.21B | ||
| -2.34% | -3.90% | +10.90% | +115.97% | 46.1B | ||
| +0.09% | -6.08% | +18.67% | +25.90% | 42.49B | ||
| -2.58% | +0.24% | +18.54% | +41.28% | 35.56B | ||
| -1.76% | -11.56% | +126.44% | +649.27% | 34.57B | ||
| +0.96% | -0.48% | +77.51% | +58.24% | 32.46B | ||
| -1.69% | -0.79% | -40.58% | +382.68% | 26.28B | ||
| Average | +7.53% | -3.40% | +33.56% | +168.96% | 44B | |
| Weighted average by Cap. | -0.82% | -3.29% | +33.69% | +143.56% |
Employees
3
















